Estimates Revisions Neuphoria Therapeutics Inc.
Stocks
NEUP
US64136E1029
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
10:49:41 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.740 USD | +0.27% |
|
-0.80% | -3.61% |
| 07-23 | Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million. | CI |
| 07-23 | Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- NEUP Stock
- Consensus Neuphoria Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
